These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 32506551)
1. Promising effect of intravenous immunoglobulin therapy for epidermolysis bullosa pruriginosa. Ertop P; Vural S; Gökpınar Ili E; Durmaz CD; Heper AO; McGrath JA; Ilgın RH; Boyvat A Int J Dermatol; 2020 Jul; 59(7):851-855. PubMed ID: 32506551 [TBL] [Abstract][Full Text] [Related]
2. An incompletely penetrant novel mutation in COL7A1 causes epidermolysis bullosa pruriginosa and dominant dystrophic epidermolysis bullosa phenotypes in an extended kindred. Yang CS; Lu Y; Farhi A; Nelson-Williams C; Kashgarian M; Glusac EJ; Lifton RP; Antaya RJ; Choate KA Pediatr Dermatol; 2012; 29(6):725-31. PubMed ID: 22515571 [TBL] [Abstract][Full Text] [Related]
3. Coinheritance of 2 New Potentially Damaging Heterozygous COL7A1 Variants in a Family With Autosomal Dominant Epidermolysis Bullosa Pruriginosa. Hale GI; Cohen MC; Quarrell OW; McGrath JA; Messenger AG Pediatr Dev Pathol; 2018; 21(6):580-584. PubMed ID: 29504492 [TBL] [Abstract][Full Text] [Related]
4. Case report. Novel and recurrent COL7A1 mutations in Chinese patients with dystrophic epidermolysis bullosa pruriginosa. Zhu KJ; Zhu CY; Zhou Y; Fan YM Genet Mol Res; 2014 Sep; 13(3):7587-92. PubMed ID: 25222259 [TBL] [Abstract][Full Text] [Related]
5. A novel splice site mutation in collagen type VII gene in a Chinese family with dominant dystrophic epidermolysis bullosa pruriginosa. Jiang W; Bu D; Yang Y; Zhu X Acta Derm Venereol; 2002; 82(3):187-91. PubMed ID: 12353709 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of epidermolysis bullosa pruriginosa by dupilumab. Wu XG; Yan S; Jiang JQ; Zhou TT; Fang X; Yang H; Bai XM; Wang H; Luo X J Dermatol; 2023 Jun; 50(6):837-842. PubMed ID: 36694424 [TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular dilemmas in the diagnosis of familial epidermolysis bullosa pruriginosa. Ee HL; Liu L; Goh CL; McGrath JA J Am Acad Dermatol; 2007 May; 56(5 Suppl):S77-81. PubMed ID: 17434045 [TBL] [Abstract][Full Text] [Related]
8. The G2028R glycine substitution mutation in COL7A1 leads to marked inter-familiar clinical heterogeneity in dominant dystrophic epidermolysis bullosa. Nakamura H; Sawamura D; Goto M; Sato-Matsumura KC; LaDuca J; Lee JY; Masunaga T; Shimizu H J Dermatol Sci; 2004 May; 34(3):195-200. PubMed ID: 15113589 [TBL] [Abstract][Full Text] [Related]
9. Identical COL71A1 heterozygous mutations resulting in different dystrophic epidermolysis bullosa phenotypes. Knöpfel N; Noguera-Morel L; Hernández-Martin A; García-Martin A; García M; Mencía Á; Pedrero RM; de Lucas R; Escámez MJ; Torrelo A Pediatr Dermatol; 2018 Mar; 35(2):e94-e98. PubMed ID: 29272047 [TBL] [Abstract][Full Text] [Related]
10. A novel missense mutation in the COL7A1 gene underlies epidermolysis bullosa pruriginosa. Chuang GS; Martinez-Mir A; Yu HS; Sung FY; Chuang RY; Cserhalmi-Friedman PB; Christiano AM Clin Exp Dermatol; 2004 May; 29(3):304-7. PubMed ID: 15115517 [TBL] [Abstract][Full Text] [Related]
11. A novel missense mutation in the COL7A1 gene causes epidermolysis bullosa pruriginosa. Shi BJ; Feng J Clin Exp Dermatol; 2009 Dec; 34(8):e975-8. PubMed ID: 19486043 [TBL] [Abstract][Full Text] [Related]
12. Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity. Darbord D; Hickman G; Pironon N; Barbieux C; Bonnet-des-Claustres M; Titeux M; Miskinyte S; Cordoliani F; Vignon-Pennamen MD; Amode R; Hovnanian A; Bourrat E J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):133-143. PubMed ID: 34543471 [TBL] [Abstract][Full Text] [Related]
14. Exon 87 skipping of the COL7A1 gene in dominant dystrophic epidermolysis bullosa. Koga H; Hamada T; Ishii N; Fukuda S; Sakaguchi S; Nakano H; Tamai K; Sawamura D; Hashimoto T J Dermatol; 2011 May; 38(5):489-92. PubMed ID: 21352278 [TBL] [Abstract][Full Text] [Related]
15. A founder synonymous COL7A1 mutation in three Danish families with dominant dystrophic epidermolysis bullosa pruriginosa identifies exonic regulatory sequences required for exon 87 splicing. Covaciu C; Grosso F; Pisaneschi E; Zambruno G; Gregersen PA; Sommerlund M; Hertz JM; Castiglia D Br J Dermatol; 2011 Sep; 165(3):678-82. PubMed ID: 21574979 [TBL] [Abstract][Full Text] [Related]
16. The clinical phenotype and a novel COL7A1 mutation in a Chinese family with dystrophic epidermolysis bullosa pruriginosa. Mu YZ; Du ZC; Zhang ZZ; Yang H; Chen X; Wang YB; Liu LL J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):e372-e373. PubMed ID: 29512192 [No Abstract] [Full Text] [Related]
17. Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations. von Bartenwerffer W; Has C; Arin MJ; Tantcheva-Poór I; Kreuter A; Kremer K; Arshah T; Hoffmann M; Eming SA; Kohlhase J; Krieg T; Bruckner-Tuderman L; Hartmann K Eur J Dermatol; 2011; 21(2):170-2. PubMed ID: 21382783 [TBL] [Abstract][Full Text] [Related]
18. A novel mutation in the COL7A1 gene results in a unique phenotype of epidermolysis bullosa pruriginosa. Ni C; Zhang J; Zhang H; Cheng RH; Liang JY; Li CX; Li M; Yao ZR J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):535-6. PubMed ID: 25556825 [No Abstract] [Full Text] [Related]